Developmental pharmacokinetic changes of lamivudine in infants and children
Lamivudine is a nucleoside reverse transcriptase inhibitor widely used in infants and children in combination antiretroviral therapy to treat human immunodeficiency virus (HIV) infection. Developmental changes in lamivudine pharmacokinetic disposition were assessed by combining data from 7 studies o...
Saved in:
Main Authors: | Adriana H. Tremoulet, Mina Nikanjam, Tim R. Cressey, Kulkanya Chokephaibulkit, Ross McKinney, Mark Mirochnick, Edmund V. Capparelli |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84868629145&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51832 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Developmental pharmacokinetic changes of lamivudine in infants and children
by: Tremoulet A.H., et al.
Published: (2014) -
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
by: Kulkanya Chokephaibulkit, et al.
Published: (2018) -
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children
by: Kulkanya Chokephaibulkit, et al.
Published: (2018) -
Efavirenz pharmacokinetics during pregnancy and infant washout
by: Regis Kreitchmann, et al.
Published: (2019) -
Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine
by: Kulkanya Chokephaibulkit, et al.
Published: (2018)